#drug-prices

#drug-prices

President Trump incorrectly blamed foreign nations for high U.S. drug prices, claiming they force companies into lower pricing, but U.S. pricing negotiations drive costs higher.

"The plan was met with skepticism from many economists, and it is likely to be challenged in court as beyond the constitutional limits of the president."

President Trump plans to sign an executive order directing drug makers to reduce medication prices by 30% to 80% to align with international costs.

One policy advocate described the move as "a total capitulation to the demands of drug corporation lobbyists."

President Trump's administration initiated an investigation into the national security risks of imported medicines, potentially leading to tariffs that could affect drug prices.